Clinical trials
Active, not recruiting Kidney Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 56 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 5 |
| M.D. Anderson Cancer Center | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 3 |
| AstraZeneca | 2 |
| Actuate Therapeutics Inc. | 1 |
| Ajjai Alva, MD | 1 |
| Arsenal Biosciences, Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| Centre of Postgraduate Medical Education | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 56 |
| Carcinoma, Renal Cell | 29 |
| Neoplasms | 9 |
| Urinary Bladder Neoplasms | 9 |
| Lung Neoplasms | 8 |
| Prostatic Neoplasms | 8 |
| Breast Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Colorectal Neoplasms | 5 |
| Head and Neck Neoplasms | 5 |
Trials
Showing 76 to 56 of 56. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.